Efficacy and limits of somatostatin analogs.


For a considerable time, somatostatin analogs have been the medical therapy of choice for the treatment of acromegaly. In addition to their well-established use as an adjunctive therapy, primary therapy with somatostatin analogs has been investigated in recent years. Adjunctive therapy with octreotide long-acting release over 12-36 months allowed for… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics